Results 191 to 200 of about 581,647 (319)

Successful Chimeric Antigen Receptor (CAR) T-Cell Treatment in Aggressive Lymphoma Despite Coronavirus Disease 2019 (CoVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication - Case Report [PDF]

open access: gold, 2021
Verena Nilius‐Eliliwi   +8 more
openalex   +1 more source

Safety and Effectiveness of Dimethyl Fumarate in Japanese Patients With Multiple Sclerosis: 2‐Year Post‐Marketing Surveillance Data

open access: yesNeurology and Clinical Neuroscience, EarlyView.
ABSTRACT Background Dimethyl fumarate (DMF) is an orally administered disease‐modifying drug used for the treatment of multiple sclerosis (MS) in numerous countries worldwide. Aim An ongoing post‐marketing surveillance (PMS) is assessing the real‐world safety and effectiveness of DMF in Japanese patients with MS.
Hirofumi Ochi   +15 more
wiley   +1 more source

Efficacy of acupuncture and moxibustion in adjuvant treatment of patients with novel coronavirus disease 2019 (COVID-19)

open access: gold, 2020
Qiongshuai Zhang   +8 more
openalex   +1 more source

Physiological barriers to oral intake in survivors of critical illness: A scoping review

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Oral nutrition is the predominant mode of nutrition delivery on the post–Intensive Care Unit (ICU) ward; yet, it is associated with lower intake than via enteral or parenteral nutrition. There are limited data on barriers that influence oral intake in ICU survivors.
Breanna J. Teleki   +4 more
wiley   +1 more source

Serum zinc level independently predicts need for inpatient intubation among patients hospitalized with COVID‐19: A prospective observational study

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Background The coronavirus disease 2019 (COVID‐19) pandemic caused significant morbidity and mortality. Further study of modifiable factors influencing COVID‐19 severity and outcomes continues to be necessary. Serum zinc levels may play a role in modulating COVID‐19 virus replication and consequently influence clinical outcomes.
Scott W. McPherson   +10 more
wiley   +1 more source

Fungal antigenemia in patients with severe Coronavirus disease 2019 (COVID-19): The facts and challenges

open access: gold, 2020
Yake Lei   +13 more
openalex   +1 more source

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial [PDF]

open access: hybrid, 2020
Andrey A. Ivashchenko   +20 more
openalex   +1 more source

Home - About - Disclaimer - Privacy